GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Beginning Cash Position

ALMS (Alumis) Beginning Cash Position : $214.44 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alumis Beginning Cash Position?

Alumis's Beginning Cash Position for the quarter that ended in Dec. 2024 was $214.44 Mil.

Alumis's quarterly Beginning Cash Position increased from Jun. 2024 ($113.21 Mil) to Sep. 2024 ($156.25 Mil) and increased from Sep. 2024 ($156.25 Mil) to Dec. 2024 ($214.44 Mil).

Alumis's annual Beginning Cash Position declined from Dec. 2022 ($101.80 Mil) to Dec. 2023 ($26.95 Mil) but then increased from Dec. 2023 ($26.95 Mil) to Dec. 2024 ($47.13 Mil).

Alumis Beginning Cash Position Historical Data

The historical data trend for Alumis's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis Beginning Cash Position Chart

Alumis Annual Data
Trend Dec22 Dec23 Dec24
Beginning Cash Position
101.80 26.95 47.13

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only 55.28 47.13 113.21 156.25 214.44

Alumis Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Alumis Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Alumis's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Alumis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Beginning Cash Position
Comparable Companies
THRD CADL CDTX HUMA FHTX PLX PRME NVCT DSGN NGNE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
280 East Grand Avenue, South San Francisco, CA, USA, 94080
Website
https://www.alumis.com
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.